Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Biology & Therapy

• Publication date

  2017-07-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/15384047.2017.1345391PMID 28686074PMCID PMC5653185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphorylation of Ku dictates DNA double-strand break (DSB) repair pathway choice in S phase

  2015cited by this paper
• Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance

  2015cited by this paper
• BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts

  2015cited by this paper
• ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development

  2015cited by this paper
• IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and dna repair associated molecules

  2015cited by this paper
• ATM and ATR as therapeutic targets in cancer.

  2015cited by this paper
• The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect

  2015cited by this paper
• Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy

  2015cited by this paper
• Interplay between the DNA Damage Proteins MDC1 and ATM in the Regulation of the Spindle Assembly Checkpoint

  2014cited by this paper
• Systems biology of cisplatin resistance: past, present and future

  2014cited by this paper
• Constitutive activation of the ATM/BRCA1 pathway prevents DNA damage-induced apoptosis in 5-azacytidine-resistant cell lines.

  2014cited by this paper
• Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis

  2014cited by this paper
• Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells

  2014cited by this paper
• Bimodal regulation of p21waf1 protein as function of DNA damage levels

  2014cited by this paper
• Radiation-induced signaling pathways that promote cancer cell survival (Review)

  2014cited by this paper
• The ATM protein kinase: regulating the cellular response to genotoxic stress, and more

  2013cited by this paper
• Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature

  2013cited by this paper
• The mTOR pathway negatively controls ATM by up-regulating miRNAs

  2013cited by this paper
• A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo

  2013cited by this paper
• Cisplatin associated with LY294002 increases cytotoxicity and induces changes in transcript profiles of glioblastoma cells

  2013cited by this paper
• Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer

  2013cited by this paper
• Cisplatin resistance associated with PARP hyperactivation.

  2013cited by this paper
• Molecular mechanisms of cisplatin resistance

  2012cited by this paper
• Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.

  2012cited by this paper
• Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC.

  2011cited by this paper
• Mcl‐1; the molecular regulation of protein function

  2010cited by this paper
• Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis

  2010cited by this paper
• Cellular Responses to Cisplatin-Induced DNA Damage

  2010cited by this paper
• MCL-1 localizes to sites of DNA damage and regulates DNA damage response

  2010influential reference
• The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.

  2010cited by this paper
• An essential role for MCL-1 in ATR-mediated CHK1 phosphorylation.

  2008cited by this paper
• Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation.

  2008cited by this paper
• The DNA damage response pathways: at the crossroad of protein modifications

  2008cited by this paper
• Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways

  2007cited by this paper
• DNA Damage-Induced Acetylation of Lysine 3016 of ATM Activates ATM Kinase Activity

  2007cited by this paper
• MLH1- and ATM-dependent MAPK Signaling Is Activated through c-Abl in Response to the Alkylator N-Methyl-N′-nitro-N′-nitrosoguanidine*

  2007cited by this paper
• p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.

  2007cited by this paper
• Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells

  2005influential reference
• A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1.

  2005cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Lung cancer: a review.

  2002cited by this paper
• Cooperative Regulation of Mcl-1 by Janus Kinase/STAT and Phosphatidylinositol 3-Kinase Contribute to Granulocyte-Macrophage Colony-Stimulating Factor-Delayed Apoptosis in Human Neutrophils1

  2001cited by this paper
• Regulation of Apoptosis and Cell Cycle Progression by MCL1

  2000cited by this paper
• In vivo localisation and stability of human Mcl‐1 using green fluorescent protein (GFP) fusion proteins

  2000cited by this paper
• Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells.

  1999cited by this paper
• Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.

  1999cited by this paper
• p53 Status Does Not Determine Outcome of E1B 55-Kilodalton Mutant Adenovirus Lytic Infection

  1998cited by this paper
• The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2

  1995cited by this paper
• Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.

  1995cited by this paper
• Lung cancer: a review.

  1975cited by this paper

• FAM172A promotes epithelial ovarian cancer progression and induces platinum resistance via the PI3K/AKT pathway

  2025cites this paper
• MicroRNA-29b-3p reduces cisplatin resistance in non-small cell lung cancer by targeting myeloid cell leukemia-1

  2024cites this paper
• The Role of miR-29a and miR-143 on the Anti-apoptotic MCL-1/cIAP-2 Genes Expression in EGFR Mutated Non-small Cell Lung Carcinoma Patients

  2024cites this paper
• GraphComm: A Graph-based Deep Learning Method to Predict Cell-Cell Communication in single-cell RNAseq data

  2024cites this paper
• Nanomedicine Combats Drug Resistance in Lung Cancer

  2023cites this paper
• Identification of Potent Inhibitors Targeting EGFR and HER3 for Effective Treatment of Chemoresistance in Non-Small Cell Lung Cancer

  2023cites this paper
• Silence of URI in gastric cancer cells promotes cisplatin-induced DNA damage and apoptosis.

  2023cites this paper
• A novel necroptosis-related LncRNA signature for prediction of prognosis and therapeutic responses of head and neck squamous cell carcinoma

  2022cites this paper
• Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells

  2022cites this paper
• Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance

  2022cites this paper
• DNA repair pathways and their roles in drug resistance for lung adenocarcinoma

  2021cites this paper
• Chemosensitizing activity of peptide from Lentinus squarrosulus (Mont.) on cisplatin-induced apoptosis in human lung cancer cells

  2021cites this paper
• Mechanisms of resistance to chemotherapy in non-small cell lung cancer

  2021cites this paper
• CMAR_A_237323 5243..5254

  2020cites this paper
• Honokiol Suppressed Pancreatic Cancer Progression via miR-101/Mcl-1 Axis

  2020cites this paper
• Breathing New Life into the Mechanisms of Platinum Resistance in Lung Adenocarcinoma

  2020cites this paper
• Abnormal expression of p-ATM/CHK2 in nasal extranodal NK/T cell lymphoma, nasal type, is correlated with poor prognosis

  2020cites this paper
• Small Molecule Inhibitors Targeting the Key Proteins in DNA Damage Response for Cancer Therapy.

  2020cites this paper
• Inhibition of SKP2 Activity Impaired ATM-Mediated DNA Repair and Enhanced Sensitivity of Cisplatin-Resistant Mantle Cell Lymphoma Cells

  2019cites this paper
• Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway

  2019influential citation
• NF&kgr;B and TNF&agr; as individual key molecules associated with the cisplatin‐resistance and radioresistance of lung cancer

  2019cites this paper
• A tight balance of Karyopherin β1 expression is required in cervical cancer cells

  2018cites this paper
• Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A

  2018cites this paper